GeekWire

Cardiac Dimensions lands $53M to fund research and expansion of heart valve technology

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors. Its total funding is more than $200 million. Cardiac ...
Morningstar%2c Inc.

Cardiac Dimensions® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour ...

Cardiac Dimensions is committed to addressing the rapidly growing patient population suffering from heart failure with functional mitral regurgitation. With decades of clinical experience and ...
Business Wire

Cardiac Dimensions Raises $53 Million Series E Financing

KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions ®, a leader in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), today announced the close of an ...

Cardiac Prosthetic Devices Market Size, Share, Trends, Competitive Landscape, and Forecast, 2026 to 2034 | 5.5% CAGR Fueled by Leadless Pacemakers and Transcatheter Valves

Minimally invasive valves, leadless pacemakers and remote monitoring drive adoption; hospitals lead demand, while Asia-Pacific offers strong expansion opportunitiesDublin, Sept. 30, 2026 (GLOBE ...
Business Wire

Cardiac Dimensions Raises $35 Million in Series D Financing

Funds Expected to Support Enrollment in U.S. Pivotal EMPOWER Trial and European Commercial Expansion for Carillon Mitral Contour System® KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, a leader ...